Client News

PL BioScience Announces new Board Member Ole Henrik Bang-Andreasen

Third BIOTECH SUMMIT AUSTRIA Gathers Industry Leaders in Graz

Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts

Secarna Pharmaceuticals enters discovery and co-development agreement with Scenic Biotech to develop disease-modifying oligonucleotide therapy against a novel drug target

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma

smartbax announces a €4.7 M Pre-Series A round to advance novel antibiotic compound through preclinical stage

Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline

InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe

ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease